Laboratory Corporation of America® Holdings (NYSE: LH) today announced the successful completion of the cash tender offer by its wholly owned subsidiary, OCM Acquisition Corp., for all outstanding ... read more

Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on December 9, 2011, LabCorp’s previously announced cash ... read more

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the nationwide availability of a new FDA-approved diagnostic for melanoma patients. ... read more

Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on October 7, 2011 LabCorp’s previously announced cash ... read more

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the results of its offer (the “Offer”) to purchase its Zero Coupon Convertible Subordinated Notes due 2021 (the ... read more

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that it has extended the term of its agreement with UnitedHealthcare Insurance Company (UnitedHealthcare), an ... read more

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America ... read more

Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the nationwide availability of a nucleic acid sequencing assay that reports NS3 and NS4A mutations and NS3 associated ... read more